FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16395611000001104: Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57391801000001112 Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57391901000001118 Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Is a Bicalutamide 50mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Has AMP Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Has specific active ingredient Bicalutamide true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Bicalutamide 50mg tablets (Bluefish Pharmaceuticals AB) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start